Brief: Alzamend Neuro Announces $4 Mln Additional Investment From Digital Power Lending
28/04/2022 11:38
April 28 (Reuters) - Alzamend Neuro Inc ALZN.O :
* ALZAMEND NEURO ANNOUNCES $4 MILLION ADDITIONAL INVESTMENT FROM DIGITAL
POWER
LENDING UPON COMPLETION OF PHASE 1 FIRST-IN-HUMAN CLINICAL TRIAL FOR AL001
TREATMENT OF DEMENTIA RELATED TO ALZHEIMER’S
Source text for Eikon: ID:nBw8tHxKha
Further company coverage: ALZN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alzamend Neuro
See all newsAlzamend Neuro Inc reports results for the quarter ended April 30 - Earnings Summary
Alzamend Neuro Inc expected to post a loss of 23 cents a share - Earnings Preview
Alzamend Neuro Inc expected to post a loss of 56 cents a share - Earnings Preview
Alzamend Neuro Inc reports results for the quarter ended April 30 - Earnings Summary
Alzamend Neuro Inc expected to post a loss of 67 cents a share - Earnings Preview